Conversely to TKIs, mAbs partly exert their cytotoxic effects by reducing EGFR ectodomain density through induction of receptor mediated endocytosis or by activating antibody-dependent cellular cytotoxicity (ADCC) towards EGFR positive cancer cells [19–21]. This evidence concerns the gene EGFR and cancer.